The veterinary profession is dedicated to the promotion of animal welfare and prevention of disease, as well as the protection of the public health. As such, the AVMA believes that it is vitally important to maintain and encourage the development of new technologies to fulfill this commitment. Accordingly, the veterinary profession should be allowed access to use fluoroquinolones in a judicious manner and conscious of the importance of public health. The AVMA believes that the new animal drug application (NADA) process provides a well-established scientific basis for animal drug approvals. The AVMA supports continued adherence by the FDA to the established NADA approval procedures to maintain the scientific integrity of the process.